These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


252 related items for PubMed ID: 28554764

  • 1. Pigmented trichoblastoma developed in a sebaceous nevus: HRAS mutation as a common molecular driver.
    Saraggi D, Salmaso R, Valentini E, Munari G, Vindigni V, Rugge M, Fassan M, Cerroni L.
    Pathol Res Pract; 2017 Jul; 213(7):860-862. PubMed ID: 28554764
    [Abstract] [Full Text] [Related]

  • 2. Nevus Sebaceous of Jadassohn With Eight Secondary Tumors of Follicular, Sebaceous, and Sweat Gland Differentiation.
    Liu Y, Valdebran M, Chen J, Elbendary A, Wu F, Xu M.
    Am J Dermatopathol; 2016 Nov; 38(11):861-866. PubMed ID: 27097338
    [No Abstract] [Full Text] [Related]

  • 3. Genetic analyses of a secondary poroma and trichoblastoma in a HRAS-mutated sebaceous nevus.
    Minowa T, Kamiya T, Hida T, Okura M, Kato J, Idogawa M, Tange S, Hirano T, Tokino T, Uhara H.
    J Dermatol; 2021 Aug; 48(8):1268-1272. PubMed ID: 33908086
    [Abstract] [Full Text] [Related]

  • 4. Phacomatosis pigmentokeratotica is caused by a postzygotic HRAS mutation in a multipotent progenitor cell.
    Groesser L, Herschberger E, Sagrera A, Shwayder T, Flux K, Ehmann L, Wollenberg A, Torrelo A, Bagazgoitia L, Diaz-Ley B, Tinschert S, Oschlies I, Singer S, Mickler M, Toll A, Landthaler M, Real FX, Hafner C.
    J Invest Dermatol; 2013 Aug; 133(8):1998-2003. PubMed ID: 23337891
    [Abstract] [Full Text] [Related]

  • 5. Rapidly growing pigmented tumor on a scalp nevus sebaceous of a pediatric patient: Observation or excision.
    Gaitan-Gaona F, Said MC, Galvan-Linares A, Palafox-Vigil G, Valdes-Rodriguez R.
    Dermatol Online J; 2014 Jul 15; 20(7):. PubMed ID: 25046468
    [Abstract] [Full Text] [Related]

  • 6. Mutation analysis of CTNNB1 gene and the ras pathway genes KRAS, NRAS, BRAF, and PIK3CA in eyelid sebaceous carcinomas.
    Kwon MJ, Nam ES, Cho SJ, Park HR, Min SK, Seo J, Choe JY.
    Pathol Res Pract; 2017 Jun 15; 213(6):654-658. PubMed ID: 28551389
    [Abstract] [Full Text] [Related]

  • 7. Schimmelpenning-Feuerstein-Mims syndrome induced by HRAS Gly12Ser somatic mosaic mutation: Case report and literature review.
    Ono H, Yamaguchi R, Arai M, Togi S, Ura H, Niida Y, Shimizu A.
    J Dermatol; 2023 Sep 15; 50(9):1213-1215. PubMed ID: 37170693
    [Abstract] [Full Text] [Related]

  • 8. Association of nevus of Jadassohn, sebaceoma and trichoblastoma in a scalp lesion.
    Brafa A, Vaccaro M, Campana M, Nisi G, Mourmouras V, Miracco C, D'Aniello C.
    Acta Dermatovenerol Croat; 2011 Sep 15; 19(4):275-7. PubMed ID: 22185931
    [No Abstract] [Full Text] [Related]

  • 9. Identification of KRAS mutation in a patient with linear nevus sebaceous syndrome: a case report.
    Pan C, Zhou X, Hong A, Fang F, Wang Y.
    BMC Med Genomics; 2020 Dec 12; 13(1):188. PubMed ID: 33308209
    [Abstract] [Full Text] [Related]

  • 10. Syringocystadenoma papilliferum and trichoblastoma arising in the nevus sebaceous.
    Wang F, Wu Y, Zheng Z, Bai Y.
    Indian J Pathol Microbiol; 2018 Dec 12; 61(1):106-108. PubMed ID: 29567896
    [Abstract] [Full Text] [Related]

  • 11. A Case of Apocrine Carcinoma Arising in a Sebaceous Naevus: Detection of HRAS G13R Mutation.
    Katsuie S, Kiniwa Y, Mikoshiba A, Goto K, Okuyama R.
    Acta Derm Venereol; 2022 Apr 13; 102():adv00697. PubMed ID: 35393630
    [No Abstract] [Full Text] [Related]

  • 12. Sebaceous carcinoma, trichoblastoma, and sebaceoma with features of trichoblastoma in nevus sebaceus.
    Misago N, Kodera H, Narisawa Y.
    Am J Dermatopathol; 2001 Oct 13; 23(5):456-62. PubMed ID: 11801780
    [Abstract] [Full Text] [Related]

  • 13. Syringocystadenocarcinoma Papilliferum In Situ, a Variant of Cutaneous Adenocarcinoma In Situ: A Case Report With Literature Review.
    Chen J, Beg M, Chen S.
    Am J Dermatopathol; 2016 Oct 13; 38(10):762-5. PubMed ID: 27533073
    [Abstract] [Full Text] [Related]

  • 14. Phacomatosis pigmentokeratotica: Postzygotic HRAS mutation with malignant degeneration of the sebaceous naevus.
    Cranwell WC, Walsh M, Winship I.
    Australas J Dermatol; 2019 Aug 13; 60(3):e245-e246. PubMed ID: 30767209
    [No Abstract] [Full Text] [Related]

  • 15. Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome.
    Groesser L, Herschberger E, Ruetten A, Ruivenkamp C, Lopriore E, Zutt M, Langmann T, Singer S, Klingseisen L, Schneider-Brachert W, Toll A, Real FX, Landthaler M, Hafner C.
    Nat Genet; 2012 Jun 10; 44(7):783-7. PubMed ID: 22683711
    [Abstract] [Full Text] [Related]

  • 16. A rare combination of sebaceoma with carcinomatous change (sebaceous carcinoma), trichoblastoma, and poroma arising from a nevus sebaceus.
    Wang E, Lee JS, Kazakov DV.
    J Cutan Pathol; 2013 Jul 10; 40(7):676-82. PubMed ID: 23550845
    [Abstract] [Full Text] [Related]

  • 17. Oral sialadenoma papilliferum with kras mutation in a patient with linear nevus sebaceous syndrome.
    Querzoli G, Badiali G, Vitali F, Tarsitano A, De Biase D, Gabrielli L, Foschini MP.
    Pathologica; 2024 Aug 10; 116(4):254-257. PubMed ID: 39377508
    [Abstract] [Full Text] [Related]

  • 18. Aggressive Extraocular Sebaceous Carcinoma of the Scalp Involving the Brain in a Patient With Muir-Torre Syndrome.
    Hadravsky L, Kazakov DV, Stehlik J, Michal M, Curik R, Krupa P, Skalova A, Kacerovska D.
    Am J Dermatopathol; 2016 Aug 10; 38(8):618-22. PubMed ID: 26779764
    [Abstract] [Full Text] [Related]

  • 19. Analysis of KRAS, NRAS, PIK3CA, and BRAF mutational profile in poorly differentiated clusters of KRAS-mutated colon cancer.
    Reggiani Bonetti L, Barresi V, Bettelli S, Caprera C, Manfredini S, Maiorana A.
    Hum Pathol; 2017 Apr 10; 62():91-98. PubMed ID: 28025078
    [Abstract] [Full Text] [Related]

  • 20. Prevalence of RAS mutations and individual variation patterns among patients with metastatic colorectal cancer: A pooled analysis of randomised controlled trials.
    Peeters M, Kafatos G, Taylor A, Gastanaga VM, Oliner KS, Hechmati G, Terwey JH, van Krieken JH.
    Eur J Cancer; 2015 Sep 10; 51(13):1704-13. PubMed ID: 26049686
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.